Anika Reaps Benefits of Expanded Market in 2020

Anika Therapeutics' logo

Anika Therapeutics reported 4Q20 orthopedic revenue of USD $30 million, +11.2% vs. 4Q19 with full-year 2020 revenue of $122.4 million, +16% vs. 2019. The company emerged from 2020 still on track to achieve its previously stated goal of doubling revenue by 2024. By Anika’s estimates, its target addressable market grew by a factor of eight...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us